Archives

by in
Entry Author Date Location
San Diego Life Sciences Roundup: Zogenix, Arena, Sorrento, and More 03/31/14 San Diego
Genentech Joins “What’s Hot in Cancer Immunotherapy” Apr. 22 03/07/14 Seattle
Biogen, Eisai Join Up in Alzheimer’s Drug Pact 03/05/14 Boston
Merck Joins ‘What’s Hot in Cancer Immunotherapy’ Apr. 22 03/04/14 Seattle
PacBio, the Post-Hype Sleeper of Genomics 03/03/14 National
Join Xconomy for ‘What’s Hot in Cancer Immunotherapy’ on April 22 02/20/14 Seattle
Immuno-Oncology Fever Rages as Novartis Snaps Up CoStim 02/18/14 Boston
Lucigen Takes On Diagnostic Giants With On-the-Spot Pathogen Tests 01/30/14 Wisconsin
Enanta, No Longer Obscure, Seeks Slice of Big Hepatitis C Market 01/24/14 Boston
Social Media & Cancer Drugs: Conversation, not Promotion 01/23/14 Wisconsin
What Biotech Pros Will Be Chirping About at JP Morgan This Week 01/13/14 National
Tillman Gerngross, the Scientist Turned Scientific Businessman 01/09/14 Boston
How WARF Plans to Stay Relevant in Lean Times for Tech Transfer 12/20/13 Wisconsin
Arrowhead Picks Up Where Roche Left Off, Jumps Ahead in RNAi 12/20/13 Wisconsin
19 Wisconsin Company Exits Since 2008 Show State’s Strengths, Trends 12/16/13 Wisconsin
What Was Hyped, and What Fell Out of Favor, This Year in Biotech 12/16/13 National
Sam Sia’s NY Biotech Incubator Already Bustling With 16 Startups 12/13/13 New York
NYCEDC Amassing $100M Biotech Fund; Boehringer Jumps Into Kendall Square 12/04/13 New York
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
Armo BioSciences Joins the Cancer Immunotherapy Party With $20M 11/25/13 San Francisco
East Coast Biotech Roundup: Moderna, Aileron, Seres, & More 11/22/13 Boston
Big Pharma Quartet Puts $30M Behind Aileron’s P53 Peptide Drug 11/18/13 Boston
Dendreon Cuts 150 Jobs, As Prostate Cancer Drug Sales Decline 11/12/13 Seattle
Immunogen Halts Study as Cancer Drug Flops, Shares Fall 11/05/13 Boston
Genentech Does it Again, Wins FDA Approval for ‘Son of Rituxan’ 11/01/13 San Francisco
Immune Design Grabs $32.5M, Cashing in on Cancer Immunotherapy Rush 10/30/13 Seattle
The Biggest Bargains Pharma Scooped Up in the Down Years 10/28/13 National
PSivida, Alimera Shares Fall as FDA Rejects Eye Drug for Third Time 10/18/13 Boston
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech 10/16/13 Boston
East Coast Life Sciences Roundup: Moderna, Inotek, Roche, & More 10/04/13 Boston
Page 2 of 15 « previous page · next page »